Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXE6B4
|
||||
| Drug Name |
[(3-Bromophenyl)-p-tolyl-ketone]thiosemicarbazone
|
||||
| Synonyms |
CHEMBL590497
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C15H14BrN3S
|
||||
| Canonical SMILES |
Cc1ccc(cc1)\\C(=N/NC(=S)N)\\c2cccc(Br)c2
|
||||
| InChI |
InChI=1S/C15H14BrN3S/c1-10-5-7-11(8-6-10)14(18-19-15(17)20)12-3-2-4-13(16)9-12/h2-9H,1H3,(H3,17,19,20)/b18-14+
|
||||
| InChIKey |
IOXFIFMULNCUSH-NBVRZTHBSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.